\-\ Texto\\:\\ \ \(0\)\
\-\ hypertonic\\ with\\ opisthotonic\\ posturing\\,\\ a\\ very\\ high\\-pitched\\ cry\\,\\ significant\\ jaundice\\ and\\ icterus\\.\\ \\ no\\ hepatomegaly\\.\ \(0\)\
\-\ total\\ bilirubin\\:\\ 42\\.2\\ \\(\\<16\\ mg\\/dl\\)\\ \\ indirect\\ bilirubin\\:\\ 41\\.5\\ \\(0\\.1\\-0\\.7\\ mg\\/dl\\)\\ \\ rbcs\\:\\ 3\\.43\\ \\(4\\.10\\-6\\.70\\ 10x6\\/mm3\\)\\ hemoglobin\\:\\ 10\\.5\\ \\(15\\.0\\-24\\.0\\ g\\/dl\\)\\ \\ hematocrit\\:\\ 30\\.4\\ \\(44\\-70\\%\\)\\ \\ mcv\\:\\ 88\\.6\\ \\(102\\-115fl\\)\\ \\ g6pd\\ quant\\:\\ 1\\.8\\ \\(4\\.6\\-13\\.5\\ u\\/g\\ hgb\\)\ \(0\)\
\-\ exchange\\ transfusion\\ is\\ a\\ definitive\\ therapy\\ used\\ to\\ mechanically\\ remove\\ already\\ formed\\ bilirubin\\ from\\ the\\ blood\\.\\ \\ it\\ is\\ indicated\\ whenever\\ clinical\\ signs\\ of\\ bilirubin\\ encephalopathy\\ are\\ present\\,\\ in\\ patients\\ with\\ critically\\ high\\ bilirubin\\ \\(\\>25\\ mg\\/dl\\)\\,\\ or\\ when\\ the\\ bilirubin\\ continues\\ to\\ rise\\ despite\\ attempts\\ to\\ reduce\\ it\\.\\ \\ phototherapy\\ induces\\ a\\ conformational\\ change\\ in\\ the\\ bilirubin\\ molecule\\,\\ rendering\\ it\\ water\\-soluble\\ and\\ therefore\\ increases\\ its\\ excretion\\ through\\ the\\ kidneys\\ and\\ also\\ non\\-lipophilic\\.\\ \\ total\\ serum\\ bilirubin\\ needs\\ to\\ be\\ kept\\ under\\ 20\\ mg\\/dl\\.\ \(0\)\
\-\ mri\\ t2\\ flair\\ \\(2\\/25\\/08\\)\\ \\ \\-\\ \\ small\\ amount\\ of\\ hemorrhage\\ in\\ the\\ extra\\-axial\\ spaces\\ of\\ the\\ posterior\\ fossa\\,\\ consistent\\ with\\ recent\\ vaginal\\ delivery\ \(0\)\
\-\ otherwise\\ normal\\ mri\\ of\\ brain\\.\ \(0\)\
\-\ mri\\ t2\\ flair\\ \\(5\\/6\\/08\\)\\ \\â\\€\\“\\ subtle\\ prolongation\\ in\\ the\\ globi\\ pallidi\\ bilaterally\\ is\\ present\\ consistent\\ with\\ previous\\ acute\\ bilirubin\\ encephalopathy\\.\ \(0\)\
\-\ kernicterus\ \(0\)\
\-\ hyperbilirubinemia\\:\ \(0\)\
\-\ g6pd\\ deficiency\ \(0\)\
\-\ pyruvate\\ kinase\\ deficiency\ \(2\)\
\-\ alpha\\ thalassemia\ \(2\)\
\-\ spherocytosis\\ \ \(2\)\
\-\ crigler\\ najjar\ \(0\)\
\-\ abo\\/rh\\ incompatibility\ \(0\)\
\-\ gilbert\\â\\€\\™s\\ syndrome\ \(0\)\
\-\ breast\\ milk\\ jaundice\ \(0\)\
\-\ physiologic\\ jaundice\ \(0\)\
\-\ breast\\ feeding\\ jaundice\\ \\(enterohepatic\\ recirculation\\ of\\ bilirubin\\)\ \(0\)\
\-\ galactosemia\ \(1\)\
\-\ congenital\\ hypothyroidism\ \(1\)\
\-\ neurological\\ signs\\:\ \(0\)\
\-\ fetal\\ alcohol\\ syndrome\ \(2\)\
\-\ head\\ trauma\ \(29\)\
\-\ hearing\\ impairment\\ \\(in\\ older\\ patients\\)\ \(2\)\
\-\ herpes\\ simplex\\ virus\\ infection\ \(2\)\
\-\ hyperammonemia\ \(2\)\
\-\ hypothyroidism\ \(39\)\
\-\ meningitis\ \(79\)\
\-\ neonatal\\ sepsis\ \(4\)\
\-\ periventricular\\ leukomalacia\ \(3\)\
\-\ 6\\ day\\-old\\ boy\\ with\\ decreased\\ feeding\\,\\ eyes\\ rolling\\ back\\ in\\ head\\,\\ arching\\ of\\ the\\ neck\\ and\\ jaundice\\.\ \(2\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bilirubin\\:\\ 0\\.17288445563210914\ \(0\)\
\-\ jaundice\\:\\ 0\\.08560312679970118\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.06453939917763794\ \(0\)\
\-\ \\-breast\\:\\ 0\\.05179131634428449\ \(0\)\
\-\ \\:\\:\\ 0\\.0341358165903221\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.03376730731575998\ \(0\)\
\-\ deficiency\\:\\ 0\\.03094513962802371\ \(0\)\
\-\ conformational\\:\\ 0\\.029582276590491605\ \(0\)\
\-\ non\\-lipophilic\\:\\ 0\\.029582276590491605\ \(0\)\
\-\ feeding\\:\\ 0\\.029427527685390496\ \(0\)\
\-\ \\(\\:\\ 0\\.029088391660826596\ \(0\)\
\-\ \\)\\:\\ 0\\.028733061427381412\ \(0\)\
\-\ opisthotonic\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 42\\.2\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 41\\.5\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 0\\.1\\-0\\.7\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 3\\.43\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 4\\.10\\-6\\.70\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 10x6\\/mm3\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 15\\.0\\-24\\.0\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 44\\-70\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 102\\-115fl\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 4\\.6\\-13\\.5\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ u\\/g\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ phototherapy\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 2\\/25\\/08\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ 5\\/6\\/08\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ kernicterus\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-g6pd\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-pyruvate\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-alpha\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-spherocytosis\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-crigler\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ najjar\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-abo\\/rh\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ incompatibility\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-gilbert\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-physiologic\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ enterohepatic\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ recirculation\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-galactosemia\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-fetal\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-hearing\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-hyperammonemia\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-meningitis\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-neonatal\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ \\-periventricular\\:\\ 0\\.027256279340290446\ \(0\)\
\-\ flair\\:\\ 0\\.026293145127621386\ \(0\)\
\-\ 30\\.4\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ 88\\.6\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ quant\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ molecule\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ rendering\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ globi\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ \\-herpes\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ \\-hypothyroidism\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ arching\\:\\ 0\\.025895658172142243\ \(0\)\
\-\ posturing\\:\\ 0\\.024930282090089285\ \(0\)\
\-\ g6pd\\:\\ 0\\.024930282090089285\ \(0\)\
\-\ critically\\:\\ 0\\.024930282090089285\ \(0\)\
\-\ water\\-soluble\\:\\ 0\\.024930282090089285\ \(0\)\
\-\ pallidi\\:\\ 0\\.024930282090089285\ \(0\)\
\-\ rolling\\:\\ 0\\.024930282090089285\ \(0\)\
\-\ total\\:\\ 0\\.02469610729473984\ \(0\)\
\-\ hypertonic\\:\\ 0\\.024181478226618786\ \(0\)\
\-\ cry\\:\\ 0\\.024181478226618786\ \(0\)\
\-\ exchange\\:\\ 0\\.024181478226618786\ \(0\)\
\-\ induces\\:\\ 0\\.024181478226618786\ \(0\)\
\-\ hyperbilirubinemia\\:\\ 0\\.024181478226618786\ \(0\)\
\-\ high\\-pitched\\:\\ 0\\.02356966092194108\ \(0\)\
\-\ mechanically\\:\\ 0\\.02356966092194108\ \(0\)\
\-\ \\-head\\:\\ 0\\.02356966092194108\ \(0\)\
\-\ \\-congenital\\:\\ 0\\.02305237676144693\ \(0\)\
\-\ leukomalacia\\:\\ 0\\.02305237676144693\ \(0\)\
\-\ thalassemia\\:\\ 0\\.022604284839888127\ \(0\)\
\-\ 10\\.5\\:\\ 0\\.02220903975379288\ \(0\)\
\-\ whenever\\:\\ 0\\.02220903975379288\ \(0\)\
\-\ kinase\\:\\ 0\\.02220903975379288\ \(0\)\
\-\ day\\-old\\:\\ 0\\.02220903975379288\ \(0\)\
\-\ milk\\:\\ 0\\.021855480976417624\ \(0\)\
\-\ icterus\\:\\ 0\\.02153564815828231\ \(0\)\
\-\ indirect\\:\\ 0\\.021243663671739924\ \(0\)\
\-\ simplex\\:\\ 0\\.021243663671739924\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.02072637951124577\ \(0\)\
\-\ rbcs\\:\\ 0\\.02049485980826942\ \(0\)\
\-\ prolongation\\:\\ 0\\.02027828758968697\ \(0\)\
\-\ signs\\:\\ 0\\.020183731100577546\ \(0\)\
\-\ kept\\:\\ 0\\.0200748492614439\ \(0\)\
\-\ mri\\:\\ 0\\.01976452202934181\ \(0\)\
\-\ attempts\\:\\ 0\\.019529483726216466\ \(0\)\
\-\ g\\/dl\\:\\ 0\\.019365758343097565\ \(0\)\
\-\ mcv\\:\\ 0\\.019365758343097565\ \(0\)\
\-\ transfusion\\:\\ 0\\.019365758343097565\ \(0\)\
\-\ it\\:\\ 0\\.019337399844292114\ \(0\)\
\-\ virus\\:\\ 0\\.018780679862745963\ \(0\)\
\-\ rise\\:\\ 0\\.01852242133544352\ \(0\)\
\-\ excretion\\:\\ 0\\.01852242133544352\ \(0\)\
\-\ 1\\.8\\:\\ 0\\.01840038226104461\ \(0\)\
\-\ needs\\:\\ 0\\.018168862558068263\ \(0\)\
\-\ formed\\:\\ 0\\.017748852011242742\ \(0\)\
\-\ sepsis\\:\\ 0\\.017651578397574107\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.017465102386987494\ \(0\)\
\-\ remove\\:\\ 0\\.017465102386987494\ \(0\)\
\-\ impairment\\:\\ 0\\.017120625359940234\ \(0\)\
\-\ already\\:\\ 0\\.017039761092896406\ \(0\)\
\-\ hematocrit\\:\\ 0\\.01688365365787999\ \(0\)\
\-\ increases\\:\\ 0\\.016808241389920063\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.016808241389920063\ \(0\)\
\-\ syndrome\\:\\ 0\\.01640205756197746\ \(0\)\
\-\ t2\\:\\ 0\\.016232139387586254\ \(0\)\
\-\ reduce\\:\\ 0\\.016196424085242363\ \(0\)\
\-\ hgb\\:\\ 0\\.015956628904094224\ \(0\)\
\-\ eyes\\:\\ 0\\.015422854761041582\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.015277981701091218\ \(0\)\
\-\ vaginal\\:\\ 0\\.015139105136786336\ \(0\)\
\-\ continues\\:\\ 0\\.014962448313009753\ \(0\)\
\-\ patients\\:\\ 0\\.01484278254608071\ \(0\)\
\-\ delivery\\:\\ 0\\.014713763842695248\ \(0\)\
\-\ alcohol\\:\\ 0\\.014445164152515599\ \(0\)\
\-\ older\\:\\ 0\\.014445164152515599\ \(0\)\
\-\ definitive\\:\\ 0\\.014162411321583586\ \(0\)\
\-\ spaces\\:\\ 0\\.014128685362343645\ \(0\)\
\-\ consistent\\:\\ 0\\.014062404488800022\ \(0\)\
\-\ serum\\:\\ 0\\.013839498462205889\ \(0\)\
\-\ therefore\\:\\ 0\\.013544949432399223\ \(0\)\
\-\ despite\\:\\ 0\\.0133266152265366\ \(0\)\
\-\ kidneys\\:\\ 0\\.013197035239530629\ \(0\)\
\-\ subtle\\:\\ 0\\.013171709046123303\ \(0\)\
\-\ 16\\:\\ 0\\.012975699777142047\ \(0\)\
\-\ present\\:\\ 0\\.012953078885447522\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.012905050752988246\ \(0\)\
\-\ under\\:\\ 0\\.012530584090543742\ \(0\)\
\-\ indicated\\:\\ 0\\.012407800709898466\ \(0\)\
\-\ neurological\\:\\ 0\\.012407800709898466\ \(0\)\
\-\ \\-\\:\\ 0\\.012293479588646735\ \(0\)\
\-\ amount\\:\\ 0\\.011974813261094\ \(0\)\
\-\ fossa\\:\\ 0\\.011687247082889695\ \(0\)\
\-\ 25\\:\\ 0\\.011591363282741855\ \(0\)\
\-\ change\\:\\ 0\\.01117691775327464\ \(0\)\
\-\ previous\\:\\ 0\\.011135403351252671\ \(0\)\
\-\ \\<\\:\\ 0\\.011067333984905336\ \(0\)\
\-\ used\\:\\ 0\\.011000617976335442\ \(0\)\
\-\ its\\:\\ 0\\.010820575313609535\ \(0\)\
\-\ very\\:\\ 0\\.010408676572003788\ \(0\)\
\-\ 20\\:\\ 0\\.010310453812607435\ \(0\)\
\-\ otherwise\\:\\ 0\\.010299715548410554\ \(0\)\
\-\ boy\\:\\ 0\\.009747388523241514\ \(0\)\
\-\ recent\\:\\ 0\\.009639996808187239\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.009544485181798778\ \(0\)\
\-\ \\>\\:\\ 0\\.009527407767344176\ \(0\)\
\-\ back\\:\\ 0\\.009459954145461332\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0094184739547782\ \(0\)\
\-\ clinical\\:\\ 0\\.008823187248543638\ \(0\)\
\-\ brain\\:\\ 0\\.00862869638692202\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.008570559529011597\ \(0\)\
\-\ 6\\:\\ 0\\.008564161615351926\ \(0\)\
\-\ decreased\\:\\ 0\\.00852602819706228\ \(0\)\
\-\ in\\:\\ 0\\.008484507989401105\ \(0\)\
\-\ neck\\:\\ 0\\.008420278983283498\ \(0\)\
\-\ infection\\:\\ 0\\.00833562608749264\ \(0\)\
\-\ s\\:\\ 0\\.008224052574210024\ \(0\)\
\-\ when\\:\\ 0\\.008212520931597335\ \(0\)\
\-\ through\\:\\ 0\\.008144151068526404\ \(0\)\
\-\ head\\:\\ 0\\.008132890303939249\ \(0\)\
\-\ high\\:\\ 0\\.007847470003613475\ \(0\)\
\-\ trauma\\:\\ 0\\.00784231134818097\ \(0\)\
\-\ blood\\:\\ 0\\.007826882793655367\ \(0\)\
\-\ significant\\:\\ 0\\.007710896480047729\ \(0\)\
\-\ therapy\\:\\ 0\\.007666579853156419\ \(0\)\
\-\ \\,\\:\\ 0\\.007267384309188923\ \(0\)\
\-\ acute\\:\\ 0\\.007080131976867433\ \(0\)\
\-\ \\%\\:\\ 0\\.006688996756194656\ \(0\)\
\-\ posterior\\:\\ 0\\.00660952533121627\ \(0\)\
\-\ small\\:\\ 0\\.006605957330137982\ \(0\)\
\-\ to\\:\\ 0\\.00573245783144948\ \(0\)\
\-\ is\\:\\ 0\\.005660645419980459\ \(0\)\
\-\ also\\:\\ 0\\.005653085884799166\ \(0\)\
\-\ normal\\:\\ 0\\.004495343807379534\ \(0\)\
\-\ be\\:\\ 0\\.004422002427328621\ \(0\)\
\-\ from\\:\\ 0\\.004249784272329572\ \(0\)\
\-\ a\\:\\ 0\\.003992615454549677\ \(0\)\
\-\ are\\:\\ 0\\.003908972726609401\ \(0\)\
\-\ the\\:\\ 0\\.0037113901933859272\ \(0\)\
\-\ or\\:\\ 0\\.0033608145938379447\ \(0\)\
\-\ no\\:\\ 0\\.0028873964788718185\ \(0\)\
\-\ and\\:\\ 0\\.0024162282648619924\ \(0\)\
\-\ of\\:\\ 0\\.0023457141100266124\ \(0\)\
\-\ with\\:\\ 0\\.0019631573169444586\ \(0\)\
\-\ \\.\\:\\ 0\\.0010721336405238808\ \(0\)\
